REFERENCES

1.Patel S, Lyons AR, Hosking DJ.  Drugs used in the treatment of metabolic bone disease:  clinical pharmacology and therapeutic use.  Drugs.  1993;46:594-617.

2.Albright F, Reifenstein EC.  The parathyroid glands and metabolic bone disease.  Baltimore:  Williams & Wilkins; 1948.

3.Dempster DW, Shane E, Horbert W et al.  A simple method for correlative light and scanning electron microscopy of human iliac crest bone biopsies:  qualitative observations in normal and osteoporotic subjects.  J Bone Miner Res.  1986; 1:15-21.

4.Wasnich RD et al.  Osteoporosis:  critique and practicum.  Honolulu:  Banyan Press; 1989:179-213.

5.Gambert SR, Schultz BM, Hamdy RC.  Osteoporosis:  clinical features, prevention, and treatment.  Endocrinol Metab Clin North Am.  1995;    24:317-71

6.Meier D.  Disorders of skeletal aging.  In:  Cassel CK, Reisenberg DE, Sorensen LB et al, eds.  Geriatric medicine.  2nd ed.  New York:  Springer Verlag; 1990:164-183.

7.Birge SJ.  Osteoporosis and hip fracture.  Clin Geriatr Med.  1993; 9:69-86.

8.Riggs BL, Melton LJ.  The prevention and treatment of osteoporosis.  N Engl J Med.  1992; 327:620-7.

9.Riggs BL, Melton LJ.  Involutional osteoporosis.  N Engl J Med.  1986; 314:1676-84.

10.Consensus Development Conference.  Prophylaxis and treatment of osteoporosis.  Am J Med.  1991; 90:107-10.

11.Physician's Guide to Prevention and Treatment of Osteoporosis. NOF Guidelines.

12.Reid Ian R. Glucocorticoid osteoporosis-mechanisims and management. European Journal of Endocrinology. 1997;137:209-217.

13.American College of Rheumatology Task Force on Osteoporosis Guidelines.  Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis.  Arthritis Rheum.  1996; 39:1791-1801

14.Bootsma GP, Dekhuijzen PNR, Festen J, Van Herwaarden CLA. Effects of inhaled corticosteroids on bone. Netherlands Journal of Medicine. 1997;50(6):254-260.

15.Gennari C, Martini G, Nuti R. Secondary Osteoporosis. Aging 1998;10(3);214-224.

return to top of page